GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » E10

Rockwell Medical (Rockwell Medical) E10 : $-5.19 (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rockwell Medical's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.19 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 21.40% per year. During the past 5 years, the average E10 Growth Rate was 11.70% per year. During the past 10 years, the average E10 Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Rockwell Medical was 21.40% per year. The lowest was -48.50% per year. And the median was -3.00% per year.

As of today (2024-04-27), Rockwell Medical's current stock price is $1.455. Rockwell Medical's E10 for the quarter that ended in Dec. 2023 was $-5.19. Rockwell Medical's Shiller PE Ratio of today is .


Rockwell Medical E10 Historical Data

The historical data trend for Rockwell Medical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical E10 Chart

Rockwell Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.30 -10.70 -10.20 -7.29 -5.19

Rockwell Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.29 -6.39 -5.94 -5.50 -5.19

Competitive Comparison of Rockwell Medical's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Shiller PE Ratio falls into.



Rockwell Medical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rockwell Medical's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.05/129.4194*129.4194
=-0.050

Current CPI (Dec. 2023) = 129.4194.

Rockwell Medical Quarterly Data

per share eps CPI Adj_EPS
201403 -2.200 99.695 -2.856
201406 -0.880 100.560 -1.133
201409 -1.100 100.428 -1.418
201412 -1.650 99.070 -2.155
201503 -0.770 99.621 -1.000
201506 -0.550 100.684 -0.707
201509 -0.550 100.392 -0.709
201512 -1.320 99.792 -1.712
201603 -1.100 100.470 -1.417
201606 -1.210 101.688 -1.540
201609 -0.990 101.861 -1.258
201612 -1.100 101.863 -1.398
201703 -0.990 102.862 -1.246
201706 -1.540 103.349 -1.928
201709 -1.100 104.136 -1.367
201712 -1.980 104.011 -2.464
201803 -1.210 105.290 -1.487
201806 -2.640 106.317 -3.214
201809 -1.100 106.507 -1.337
201812 -1.870 105.998 -2.283
201903 -1.650 107.251 -1.991
201906 -1.980 108.070 -2.371
201909 -1.320 108.329 -1.577
201912 -1.210 108.420 -1.444
202003 -1.320 108.902 -1.569
202006 -1.100 108.767 -1.309
202009 -1.100 109.815 -1.296
202012 -0.990 109.897 -1.166
202103 -0.910 111.754 -1.054
202106 -0.990 114.631 -1.118
202109 -0.890 115.734 -0.995
202112 -1.040 117.630 -1.144
202203 -0.840 121.301 -0.896
202206 -0.430 125.017 -0.445
202209 -0.230 125.227 -0.238
202212 -0.200 125.222 -0.207
202303 -0.100 127.348 -0.102
202306 -0.180 128.729 -0.181
202309 -0.070 129.860 -0.070
202312 -0.050 129.419 -0.050

Add all the adjusted EPS together and divide 10 will get our e10.


Rockwell Medical  (NAS:RMTI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rockwell Medical E10 Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical (Rockwell Medical) Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
Executives
Jesse Neri officer: SVP, FINANCE 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau director C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted officer: See Remarks 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins officer: SVP, General Counsel 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck director, officer: President and CEO 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson director 601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie director 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond 10 percent owner, other: See Footnote 1 3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison director 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman officer: Chief Medical Officer 30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin director C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc. 10 percent owner, other: See Footnote 1 7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul director, officer: Chief Executive Officer HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith officer: Chief Financial Officer C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960